Oral Session 1-14A Immune Cell Therapy Using iPS Cells

[OS1-14A-1] Genetically engineered progenitor cells from human iPSCs enable the robust production of neutrophils

Masashi Miyauchi¹, Fumi Nakamura¹, Yusuke Ito¹, Yuki Iwasaki², Taiki Kawagoshi², Yuki Kagoya³, Shunya Arai¹, Mineo Kurokawa^1,3 (1.Hematol., Tokyo Univ., Tokyo, Japan, 2.Kyowa Hakko Kirin Co. Ltd., Research and Developmen, Tokyo, Japan, 3.Dept. Cell Therapy and Transplantation Medicine, Tokyo Univ., Tokyo, Japan)